SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): August 13, 2004. BioTime, Inc. (Exact name of registrant as specified in its charter) California 1-12830 94-3127919 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 935 Pardee Street Berkeley, California 94710 (Address of principal executive offices) (510) 845-9535 (Registrant's telephone number, including area code) Item 7. Financial Statements and Exhibits (c) Exhibits. Exhibit Numbers Description - ------- ----------- 99.1 Press Release dated August 13, 2004. Item 12. Results of Operations and Financial Condition On August 13, 2004, BioTime, Inc. issued a press release announcing its financial results for the second quarter of 2004. A copy of the press release is attached as Exhibit 99.1, which, in its entirely, is incorporated herein by reference. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOTIME, INC. Date: August 13, 2004 By /s/ Judith Segall ------------------------------- Vice President - Operations Member, Office of the President 2 Exhibit Numbers Description - ------- ----------- 99.1 Press Release dated August 13, 2004 3